Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies
Biocartis Group NV , an innovative molecular diagnostics company announced the signing of a collaboration...
Implementing a more structured approach to analytical method development
The adoption of lifecycle management to ensure the quality of pharmaceutical products has been discussed...
Lonza’s New Spheroid-Forming Human Hepatocytes Facilitate Improved In Vitro Liver Model Systems
Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids...
Sapreme Technologies in Alliance to Develop an Oligonucleotide Delivery Platform
Sapreme Technologies, a privately-held biotech company developing a technology platform to enable the cytosolic delivery...
Jubilant Biosys Expands Collaboration with Sanofi in CNS Therapeutic Area
Jubilant Biosys announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic...
Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China
Samsung Bioepis Co., Ltd. announced its expansion in mainland China through a licensing agreement with...
Pathios Therapeutics and Sygnature Discovery sign strategic partnership
Pathios Therapeutics, an innovative biotech company focused on the development of first-in-class therapies for autoimmune...
Pharm-Olam Enrolls Patients in Zealand Pharma Orphan Drug Study
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for rare and orphan diseases...
IDDI starts Collaborative Research on Ground-Breaking Statistical Method for individualization of Therapy
The treatment of patients in clinical practice relies on the results of randomized clinical trials....
Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies
Kyn Therapeutics, a clinical-stage biotechnology company advancing research into new immunometabolic therapies for treating cancer,...
